PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- José Perez
MedSIR
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
53 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hôpital Jean Minjoz
Besançon, France
- Polyclinique Bordeaux Nord Aquitaine
Bordeaux, France
- Centre Georges François Leclerc
Dijon, France
- Chd Vendee
La Roche-sur-Yon, France
- Hopital Europeen Georges Pompidou
Paris, France
- Hôpital Tenon Ap-Hp
Paris, France
- Centre Paul Strauss
Strasbourg, France
- University Hospital Dresden-Gyn
Dresden, Germany
- Kliniken Essen Mitte
Essen, Germany
- Universitätsklinikum Essen Frauenklinik
Essen, Germany
- Agaplesion Markus Krankenhaus
Frankfurt, Germany
- Technical University Munich
Munich, Germany
- Ukm Brustzentrum
Münster, Germany
- Klinikum Ernst Von Bergmann
Potsdam, Germany
- Klinikum Mutterhaus Der Borromäerinnen Trier
Trier, Germany
- Ospedale Civili Brescia
Brescia, Italy
- Instituto Europeo Di Oncologia
Milan, Italy
- Oncologia Medica Ospedale Di Prato
Prato, Italy
- Policlinico Universitario Campus Bio-Medico
Roma, Italy
- Onkološki inštitut Ljubljana
Ljubljana, Slovenia
- Univerzitetni Klinicni Center Maribor Oddelek Za Onkologijo
Maribor, Slovenia
- Ico Badalona
Badalona, Barcelona, Spain
- Hospital Provincial de Castellón
Castelló, Castelló, Spain
- Consorci Sanitari de Terrassa
Terrassa, Terrasa, Spain
- Centro Oncológico de Galicia
A Coruña, Spain
- H. Vall Hebrón
Barcelona, Spain
- Hospital del Mar
Barcelona, Spain
- Institut Català D'Oncologia Bellvitge
Barcelona, Spain
- Hospital de Basurto
Bilbao, Spain
- Hospital San Pedro de Alcantara
Cáceres, Spain
- Institut Català D'Oncologia
Girona, Spain
- Hospital Arnau de Vilanova
Lleida, Spain
- Hospital Clinico San Carlos
Madrid, Spain
- Hospital la Paz
Madrid, Spain
- Hospital Universitario Sanchinarro
Madrid, Spain
- Hospital Regional Universitario de Malaga
Málaga, Spain
- Hospital Universitari Son Espases
Palma de Mallorca, Spain
- Hospital Sant Joan
Reus, Spain
- Hospital Universitario Virgen de la Macarena
Seville, Spain
- Hospital Universitario Virgen del Rocío
Seville, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Apr 2019
- Primary completion
- 30 Nov 2022
- Completion
- 30 Nov 2022
- Last update posted
- 7 Sept 2023
- Registered enrollment
- 198
- Registry id
- NCT03809988
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.